Parotid Tumours
The patient with the parotid swelling presents a classical diagnostic problem. If it is smooth, mobile, and long-standing no matter its size then a mixed salivary tumour (pleomorphic adenoma) is the most likely diagnosis, though in some cases the diagnosis will be adenolymphoma. Fixation to the skin or deeper structures, ulceration, pain, facial palsy, or ear discharge suggest malignant change in a pleomorphic adenoma or a frankly malignant tumour such as an adenocystic or mucoepidermoid carcinoma. One may go along the traditional diagnostic road of, for example, soft tissue x-rays examination or sialograms, but at the end of the day most patients will come to surgery. If the diagnosis is in doubt a frozen section at the time of surgery may help. In pleomorphic adenoma or adenolymphoma the superficial lobe is usually involved and a superficial parotidectomy with sparing of the facial nerve is curative. In malignant tumours a total parotidectomy with or without a neck dissection is indicated and a resulting facial palsy must be accepted. If overlying skin is involved this is widely excised and if there is bony invasion then a partial petrosectomy by a combined intracranial and extracranial approach is desirable. Radiotherapy is of little value in the treatment of these lesions.
In most pleomorphic adenomata with malignant change the results of radical surgery are very good. Adenocystic and mucoepidermoid carcinomata have a definite tendency to local recurrence even years after resection. They also tend to metastasize to cervical lymph nodes and lung. Fortunately, patients may live symptomless for many years with pulmonary involvement, especially with adenocystic carcinoma.
Conclusion
Radical surgery has undoubtedly improved the prognosis in head and neck cancer, but what is the quality of life attained by the survivors ? Life is sweet and, after a difficult period of adjustment, when medical advisers and relatives must do all they can to help, most patients settle down, many return to work, and almost all are grateful for being cured; psychological problems are minimal.
Thalassaemias
The thalassaemia syndromes are a heterogeneous group of disorders characterized by a reduced rate of synthesis of one or more of the globin chains of haemoglobin. These conditions are the commonest haemoglobinopathies. They occur sporadically in every racial group and present a massive public health problem in many parts of the world. In areas where these conditions are highly prevalent, with carrier rates of between 5% and 20%, the large numbers of homozygotes cause a major drain on blood transfusion resources.
HETEOGENEITY OF THAIASSAMIAS
Many different disorders of haemoglobin synthesis can produce the clinical picture of thalassaemia. These may be classified into two main groups, however, depending on which globin chain is produced ineffectively-that is, the oc-thalassaemias and the P-thalassaemias. All the thalassaemia syndromes have in common a reduced rate of synthesis on one-half of the haemoglobin molecule and thus imbalanced globin-chain production." " In the 3-thalassaemias this leads to the production of an excess of ac-chains in many of the red-cell precursors. Since fetal haemoglobin (r-chain) synthesis persists in some cell lines part of the excess a-chain is combined with y-chains to produce haemoglobin F. This occurs in only a limited number of red-cell precursors and others are left with a large number of ac-chains with no partner chains. The uncombined a-chains are unstable and precipitate, producing large inclusion bodies. ' The presence of these inclusions causes considerable abnormalities of cellular maturation and proliferation and many of the affected red-cell precursors never leave the bone marrow. This is the mechanism for the striking degree of ineffective erythropoiesis common to all the thalassaemia disorders. Such cells as do leave the marrow have a shortened survival because they suffer damage due to the presence of rigid inclusions, and many of them are sequestered in the spleen and other parts of the reticuloendothelial system. Thus the anaemia of severe (3-thalassaemia results from a combination of ineffective production and reduced survival of the red cells.
Most of the clinical findings of p-thalassaemia can be related to the primary imbalance of globin-chain synthesis. ' ' 7 During the last few years it has been possible to use some of the newer methods of molecular biology to study these problems. Because it is easier to study the cytoplasm of a cell than its nucleus the earliest experiments examined the processes of globin-chain initiation, translation, and termination. With the development of methods for studying mRNA and DNA the trail has gradually led back to the globin genes.
ASSEMBLY OF GLOBIN CHAINS IN THALASSAEMIA
In 1961 Dintzis 9 showed that if rabbit reticulocytes-cells which are still actively synthesizing haemoglobin-are incubated with radioactive amino-acids for short periods and the globin chains are then isolated and split up into small fragments it is possible by measuring the distribution of radioactivity among these fragments to Using human mRNAs as a template they produced radioactive cDNAs and used these as probes to measure the amount of mRNA in thalassaemic cells. When DNA is heated the strands dissociate and when it is cooled they reanneal. If this is done in the presence of mRNA the latter will bind to the DNA to produce a double stranded DNA/RNA helix if there are complementary sequences present. Thus using radioactive cDNA made from human a-and P-chain mRNA it is possible to estimate the amount of mRNA in thalassaemic reticulocytes by measuring the amount of mRNA required to saturate the a-or 3-cDNA. It turns out that in (3-thalassaemic red-cell precursors there is a deficiency of P-mRNA and in a-thalassaemic red-cell precursors there is a deficiency of a-mRNA, when eamined by the cDNA/mRNA hybridization technique.
Taken together all these experiments provide strong evidence for a deficiency of mRNA in all forms of thalassaemia looked at to date. Quite recently the molecular basis for this finding has been worked out in one common form of a-thalassaemia. It turns out that these are responsible for much thalassaemiain several population groups. This type of mutation was discovered during a study of families with Hb-H disease."" This is a form of a-thalassaemia which results from the inheritance of two genes: the severe a-thalassaemia gene which is now known to result from a deletion of the a-chain loci (see above) and a milder gene which results in the production of a-chains at a reduced rate. In a Jamaican family with Hb-H disease trace amounts of a slowly migrating haemoglobin component were discovered; this was subsequently named Hb Constant Spring (Constant Spring being the suburb of Kingston where the family lived). This variant was found to have elongated a-chains which are normal up to position 141 and then have 31 extra residues attached to the end, the first of which, at position 142, is glutamine. This strange haemoglobin was thought initially to be unique to one particular family but later was shown to occur commonly throughout south-east Asia: indeed, it is now estimated that it occurs in 4% of the population of Thailand and is probably equally common in the Chinese and Malay populations of Malaysia." 30 It also has been found in Greece.
DELETION OF THE a-CHAIN GENES AS
It was suggested that Hb Constant Spring has arisen in just the same way as the many other variants-that is, by a single base change in a haemoglobin gene. In this case, however, the substitution is in the terminating codon UAA, which has changed to CAA, which is the code word for glutamine.11 Thus the chain instead of ending at position 141 has glutamine at 142. It was then necessary to postulate that there is mRNA after the terminating codon which is not normally translated. In the case of Hb Constant Spring this extra material is translated untilanother "stop" codon is reached and so an elongated chain is produced. This somewhat fanciful explanation has been confirmed recently by the discovery of two further mutant haemoglobins whose structures throw considerable light on the structure of the human a-chain mRNA. The first of these is Hb Wayne."2 Like Hb Constant Spring it has an elongated a-chain but in this case thechain is normal only up to position 138 and then its structure changes and it ends at position 146 with a terminating codon at 147. This variant seems to have resulted from a process known as a "frame shift," a mutational event known to the microbial geneticist for some years but never having been seen before in human genetics. A frame shift results from the loss of a single base so that the code words get displaced; everything is still read in threes but moved along one as it were. A glance at fig. 2 Thoughts for the future The human haemoglobin story as it has unfolded has revealed an extraordinary diversity of mutational events which can produce clinical disorders. These have included point mutations, triplet deletions, additions or insertions, total-gene deletions, chaintermination mutants, frame shifts, and abnormal cross-over products. Much still remains to be done, however. In particular we still do not know why there is a deficiency of mRNA for the r-chains in the red-cell precursors of patients with the common forms of p-thalassaemia. We now seem to have the tools to tackle this problem and it will be surprising if the answers are not forthcoming in the next few years.
What then are the benefits of this new and sophisticated knowledge to patients with these common genetic disorders ? A cynical answer might be that we can do little more for patients with sickle-cell anaemia and p-thalassaemia than could Herrick or Cooley when they first described these diseases in the 1920s. Indeed, such a view might not seem unreasonable when after many years of intensive study at least one of the common thalassaemia disorders turns out to be due to a total gene deletion for which little can be done other than to hope for some form of divine intervention.
I do not subscribe to these gloomy views, however. We have learned much already from the molecular approach to the haemoglobin disorders. Thus studies of haemoglobin synthesis have provided us with a clear picture of the pathophysiology of the thalassaemia syndromes and have shown us how best to manage them symptomatically. The development of simple techniques for separating globin chains, on which much of this work is based, has lead directly to promising methods for the antenatal diagnosis of sickle-cell anaemia and possibly for thalassaemia, which should be available within the next year or so.34 Furthermore, the pathophysiological studies have provided clear evidence that further reactivation of the y-chain genes could protect both sickle and r-thalassaemic cells from the action of the primary mutation. Thus we should now concentrate our efforts in studies of the mechanism for the switch from y-to ,3-chain production to see if this can be modified in any way. Since we know that reactivation of Hb F production occurs in pregnancy and in various disease states35 it is not inconceivable that this switch mechanism may be amenable to manipulation. With the development of techniques for isolating human o-and 5-chain genes in relatively large quantitites the possibility of gene replacement must be now considered seriously, though such research should be given low priority when compared with population education, antenatal diagnosis, and fetal haemoglobin stimulation.
All the knowledge outlined in this review has been gained within a very short period of time and it would be a pessimist indeed who could say with certainty that it was going to have no further practical value within the forseeable future.
